Clinical Trial Update: Phase 2b Study of ALTO-100 in MDD [Phase 2]

View source ↗

Summary

Alto Neuroscience's Phase 2b trial of ALTO-100 for Major Depressive Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ALTO-100

Snippet

Sponsor: Alto Neuroscience | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED